Radioiodine uptake in non-lactating mammary glands: Evidence for a causative role of hyperprolactinemia

Giuseppe Ronga, Rocco Bruno, Efisio Puxeddu, Filippo Calcinaro, Teresa Montesano, Laura Travascio, Marzia Colandrea, Cosimo Durante, Marianna Maranghi, Sebastiano Filetti, Diego Russo

Research output: Contribution to journalArticlepeer-review

Abstract

Context: Radioiodine uptake is rarely observed in normal non-lactating breast tissue. Investigation of the in vivo regulation of iodide uptake in breast tissue may be useful for the induction of radioiodine uptake in breast cancer tissue for diagnostic and therapeutic purposes. Case reports: We report the cases of two post-menopausal women who underwent radioiodine therapy for papillary thyroid carcinoma and in whom breast uptake of radioiodine on post-therapy whole body scan (WBS) was observed. Methods and results: In both patients, elevated serum prolactin levels (123 ng/mL in patient 1 and 48 ng/mL in patient 2) were documented at the time when radioiodine uptake in the breast was observed. The hyperprolactinemia was due to prolonged treatment with the antidopaminergic neuroleptic risperidone in Case 1, and chronic renal failure in Case 2. When prolactin levels were normalized (by withdrawal of risperidone in Case 1 and with cabergoline in Case 2), breast tissue uptake was no longer evident on WBS. Conclusion: These cases provide the first documented correlation between serum levels of endogenous prolactin and radioiodine uptake by involuted breast tissue in humans.

Original languageEnglish
Pages (from-to)363-366
Number of pages4
JournalThyroid
Volume17
Issue number4
DOIs
Publication statusPublished - Apr 2007

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Radioiodine uptake in non-lactating mammary glands: Evidence for a causative role of hyperprolactinemia'. Together they form a unique fingerprint.

Cite this